Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign a consent form agreeing to take part in the study and allowing their personal health information to be shared as required
- People who are willing and able to follow the study procedures, as judged by the study doctor
- People who are 18 years of age or older at the time they sign the consent form
- People whose overall health and ability to carry out daily activities falls within a certain range on a standard scale used by doctors to measure this (called the ECOG Performance Status, scored 0–2, meaning fully active to capable of limited self-care — confirm with trial site)
- People who meet all the eligibility requirements of a related "parent" study called LCCC2521, and who have already consented to take part in that study
Who may not be able to join:
- People whose cancer that has spread to other parts of the body cannot be safely reached to take a small tissue sample for research purposes
- People who have already started a second round of treatment (second-line therapy) for their condition
- People who have another illness or health condition that, in the opinion of their treating cancer doctor, makes participation in this study unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lisa A Carey, MD, UNC Lineberger Comprehensive Cancer Center
Phone: 919-984-0000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intra-Individual Progression-Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.